LMR Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2
| Closed | -$655 | – | 1441 |
|
|
2025
Q4 | $655 | Sell |
2
-32,174
| -100% | -$10.2M | ﹤0.01% | 1489 |
|
|
2025
Q3 | $9.08M | Buy |
32,176
+9,139
| +40% | +$2.65M | 0.04% | 350 |
|
|
2025
Q2 | $6.43M | Buy |
23,037
+23,032
| +460,640% | +$6.52M | 0.05% | 382 |
|
|
2025
Q1 | $1.56K | Sell |
5
-41,975
| -100% | -$12.4M | ﹤0.01% | 1312 |
|
|
2024
Q4 | $10.9M | Buy |
41,980
+37,311
| +799% | +$11.1M | 0.09% | 229 |
|
|
2024
Q3 | $1.5M | Buy |
4,669
+4,437
| +1,913% | +$1.45M | 0.01% | 670 |
|
|
2024
Q2 | $72.5K | Buy |
+232
| New | +$68.2K | ﹤0.01% | 908 |
|
|
2023
Q3 | – | Sell |
-44,344
| Closed | -$11.1M | – | 933 |
|
|
2023
Q2 | $9.85M | Buy |
44,344
+41,415
| +1,414% | +$9.61M | 0.11% | 193 |
|
|
2023
Q1 | $708K | Buy |
+2,929
| New | +$719K | 0.01% | 659 |
|
|
2022
Q4 | – | Sell |
-5,106
| Closed | -$1.15M | – | 1104 |
|
|
2022
Q3 | $1.15M | Buy |
+5,106
| New | +$1.24M | 0.02% | 677 |
|
|
2021
Q4 | – | Sell |
-11,356
| Closed | -$2.42M | – | 1146 |
|
|
2021
Q3 | $2.42M | Buy |
11,356
+9,027
| +388% | +$2.08M | 0.03% | 416 |
|
|
2021
Q2 | $568K | Sell |
2,329
-825
| -26% | -$203K | 0.01% | 646 |
|
|
2021
Q1 | $785K | Buy |
3,154
+928
| +42% | +$221K | 0.02% | 531 |
|
|
2020
Q4 | $512K | Sell |
2,226
-486
| -18% | -$112K | 0.01% | 344 |
|
|
2020
Q3 | $689K | Buy |
+2,712
| New | +$672K | 0.01% | 247 |
|
|
2019
Q4 | – | Sell |
-18,951
| Closed | -$3.67M | – | 401 |
|
|
2019
Q3 | $3.67M | Buy |
+18,951
| New | +$3.64M | 0.18% | 79 |
|
|
2019
Q2 | – | Sell |
-14,335
| Closed | -$2.72M | – | 430 |
|
|
2019
Q1 | $2.72M | Buy |
14,335
+7,888
| +122% | +$1.51M | 0.14% | 102 |
|
|
2018
Q4 | $1.25M | Buy |
+6,447
| New | +$1.26M | 0.06% | 153 |
|
|
2018
Q2 | – | Sell |
-5,451
| Closed | -$948K | – | 472 |
|
|
2018
Q1 | $948K | Hold |
5,451
| – | – | 0.1% | 186 |
|
|
2017
Q4 | $948K | Buy |
+5,451
| New | +$965K | 0.1% | 186 |
|
|
2017
Q3 | – | Sell |
-18,995
| Closed | -$3.27M | – | 322 |
|
|
2017
Q2 | $3.27M | Sell |
18,995
-214
| -1% | -$34.8K | 0.21% | 94 |
|
|
2017
Q1 | $3.15M | Buy |
19,209
+17,834
| +1,297% | +$2.96M | 0.3% | 64 |
|
|
2016
Q4 | $201K | Buy |
+1,375
| New | +$207K | 0.03% | 312 |
|
|
2016
Q3 | – | Sell |
-10,952
| Closed | -$1.67M | – | 340 |
|
|
2016
Q2 | $1.67M | Buy |
10,952
+1,606
| +17% | +$250K | 0.26% | 121 |
|
|
2016
Q1 | $1.4K | Buy |
+9,346
| New | +$1.39M | 0.15% | 132 |
|
|
2015
Q4 | – | Sell |
-8,062
| Closed | -$1.12M | – | 227 |
|
|
2015
Q3 | $1.12M | Sell |
8,062
-12,391
| -61% | -$1.95M | 0.12% | 167 |
|
|
2015
Q2 | $3.14M | Buy |
20,453
+9,833
| +93% | +$1.58M | 0.38% | 51 |
|
|
2015
Q1 | $1.7M | Sell |
10,620
-6,566
| -38% | -$1.03M | 0.23% | 117 |
|
|
2014
Q4 | $2.74M | Buy |
+17,186
| New | +$2.68M | 0.36% | 60 |
|
Other funds holding AMGN
VCM
VPM
LMR Partners's AMGN Position: Q1 2026 in Review
LMR Partners sold out of Amgen (AMGN) in Q1 2026, closing a stake of 2 shares — an estimated $655 sold.
LMR Partners first reported a position in AMGN in Q4 2014 and held it in 29 quarters. The position peaked at $10.9M in Q4 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- LMR Partners reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- LMR Partners sold 2 Amgen shares in Q1 2026, an estimated $655.
- LMR Partners first reported a position in Amgen in Q4 2014 and held it in 29 quarters.
- LMR Partners's Amgen position peaked at $10.9M in Q4 2024.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.